Creating a new tool to assess substance use in at-risk groups
Development of a novel polysubstance assessment tool for vulnerable subpopulations
This study is creating a new tool to better understand how people use multiple substances, especially those who are at risk, like those using opioids, so we can find better ways to help them stay healthy.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10857281 on NIH RePORTER |
What this research studies
This research focuses on developing a new assessment tool specifically designed to measure polysubstance use, particularly among vulnerable populations such as those using opioids. The project aims to address the gaps in current screening methods that fail to capture the complexities of substance use behaviors. By accurately measuring these behaviors, the research seeks to identify the motivations and correlates of polysubstance use, which can inform the development of targeted interventions to improve health outcomes. The principal investigator, Dr. Amanda Bunting, will enhance her skills in instrument development and validation through this project.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals from vulnerable populations who engage in polysubstance use, particularly those involving opioids.
Not a fit: Patients who do not engage in polysubstance use or are not part of vulnerable populations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better assessment tools that improve health outcomes for individuals struggling with polysubstance use.
How similar studies have performed: Other research has shown success in developing assessment tools for substance use, indicating that this approach has potential for meaningful advancements.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Bunting, Amanda M — New York University School of Medicine
- Study coordinator: Bunting, Amanda M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.